(131) have also demonstrated that different doses of metformin treatment (4.9 - 9.4 mM) administered to four types of GBM cell lines for 48 hours resulted in decreased Akt phosphorylation, cell survival, and proliferation. Here, AKT1 is linked to glioblastoma.